Ozempic and Surgery: Increased Aspiration Risk
The U.K.'s MHRA warns that weight-loss drugs like Ozempic increase the risk of aspiration (stomach contents entering the lungs) during surgery due to slow gastric emptying, reporting a small number of cases, one resulting in aspiration pneumonia; patients should inform their healthcare providers.
Ozempic and Surgery: Increased Aspiration Risk
The U.K.'s MHRA warns that weight-loss drugs like Ozempic increase the risk of aspiration (stomach contents entering the lungs) during surgery due to slow gastric emptying, reporting a small number of cases, one resulting in aspiration pneumonia; patients should inform their healthcare providers.
Progress
52% Bias Score
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes showed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues but increased the risk of 19 others, highlighting both benefits and risks of this increasingly popular medication.
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes showed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues but increased the risk of 19 others, highlighting both benefits and risks of this increasingly popular medication.
Progress
36% Bias Score
Fluoroquinolone Antibiotic Side Effects: Long-Term Disability and Underreporting
John Marshall, 51, from Kirkcaldy, Scotland, experienced debilitating joint pain and muscle spasms after taking fluoroquinolone antibiotics in 2017; seven years later, he still suffers chronic pain and muscle spasms, highlighting the rare but severe and potentially irreversible side effects of these...
Fluoroquinolone Antibiotic Side Effects: Long-Term Disability and Underreporting
John Marshall, 51, from Kirkcaldy, Scotland, experienced debilitating joint pain and muscle spasms after taking fluoroquinolone antibiotics in 2017; seven years later, he still suffers chronic pain and muscle spasms, highlighting the rare but severe and potentially irreversible side effects of these...
Progress
48% Bias Score
Ozempic Linked to Doubled Risk of Rare Eye Disease
Two studies from the University of Southern Denmark reveal a doubled risk of developing a rare, irreversible eye disease among Ozempic users compared to non-users; health authorities are monitoring the situation closely.
Ozempic Linked to Doubled Risk of Rare Eye Disease
Two studies from the University of Southern Denmark reveal a doubled risk of developing a rare, irreversible eye disease among Ozempic users compared to non-users; health authorities are monitoring the situation closely.
Progress
44% Bias Score
Ozempic and Increased Risk of Blindness: New Studies Reveal Elevated NAION Risk
New studies in Denmark and Norway reveal that Ozempic, a popular diabetes medication used for weight loss, more than doubles the risk of NAION (non-arteritic anterior ischemic optic neuropathy), a severe eye disease potentially causing blindness, compared to alternative treatments; these findings co...
Ozempic and Increased Risk of Blindness: New Studies Reveal Elevated NAION Risk
New studies in Denmark and Norway reveal that Ozempic, a popular diabetes medication used for weight loss, more than doubles the risk of NAION (non-arteritic anterior ischemic optic neuropathy), a severe eye disease potentially causing blindness, compared to alternative treatments; these findings co...
Progress
52% Bias Score
Nurse's Death Linked to Weight-Loss Drug Mounjaro
A 58-year-old nurse died after taking the weight-loss drug Mounjaro, raising concerns about its safety and the UK government's plans for a large-scale trial.
Nurse's Death Linked to Weight-Loss Drug Mounjaro
A 58-year-old nurse died after taking the weight-loss drug Mounjaro, raising concerns about its safety and the UK government's plans for a large-scale trial.
Progress
0% Bias Score
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes revealed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues, including cardiovascular problems and infections, but increased risks of gastrointestinal issues and low blood pressure.
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes revealed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues, including cardiovascular problems and infections, but increased risks of gastrointestinal issues and low blood pressure.
Progress
40% Bias Score
NHS Wait Times Fuel Unsafe Online Weight-Loss Drug Purchases
Britain's top GP warns that long waits for NHS weight-loss services are driving people to buy potentially unsafe drugs online, as some patients face up to five-year waits for specialist support, while the NHS rollout of Mounjaro, a key weight-loss jab, is scheduled for 12 years, impacting an estimat...
NHS Wait Times Fuel Unsafe Online Weight-Loss Drug Purchases
Britain's top GP warns that long waits for NHS weight-loss services are driving people to buy potentially unsafe drugs online, as some patients face up to five-year waits for specialist support, while the NHS rollout of Mounjaro, a key weight-loss jab, is scheduled for 12 years, impacting an estimat...
Progress
48% Bias Score
FDA Issues Black Box Warning for Veozah Due to Liver Damage Risk
The FDA issued a black box warning for the drug Veozah, used to treat hot flashes, due to rare but serious liver damage, mandating frequent blood tests and immediate reporting of symptoms.
FDA Issues Black Box Warning for Veozah Due to Liver Damage Risk
The FDA issued a black box warning for the drug Veozah, used to treat hot flashes, due to rare but serious liver damage, mandating frequent blood tests and immediate reporting of symptoms.
Progress
32% Bias Score
FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.
FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.
Progress
32% Bias Score
Minoxidil Use Linked to 'Werewolf Syndrome' in European Infants
Eleven cases of hypertrichosis ('werewolf syndrome') in European infants were linked to parental use of topical minoxidil, prompting the European Medicines Agency (EMA) to update medication information with warnings about this potential side effect.
Minoxidil Use Linked to 'Werewolf Syndrome' in European Infants
Eleven cases of hypertrichosis ('werewolf syndrome') in European infants were linked to parental use of topical minoxidil, prompting the European Medicines Agency (EMA) to update medication information with warnings about this potential side effect.
Progress
52% Bias Score
Novo Nordisk: Deaths Linked to Compounded Copies of Wegovy and Ozempic
Novo Nordisk reports deaths and hospitalizations linked to compounded copies of its drugs, prompting a request for FDA ban.
Novo Nordisk: Deaths Linked to Compounded Copies of Wegovy and Ozempic
Novo Nordisk reports deaths and hospitalizations linked to compounded copies of its drugs, prompting a request for FDA ban.
Progress
0% Bias Score